Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Low Energy Bioimaging through Molecular Up-Conversion Emission with Imidazolium- and Benzenetriol-Based Er(III) Complexes.

Journal of the American Chemical Society·2026
Same author

Multiplexed single-tier immunoassay for improved Lyme disease diagnosis across all disease stages.

Research square·2026
Same author

The Medicinal Mushroom <i>Ganoderma</i>: A Review of Systematics, Phylogeny, and Metabolomic Insights.

Journal of fungi (Basel, Switzerland)·2026
Same author

Assessing completeness of cancer family history in EHRs using genetically defined kinships: A cross-sectional study.

Genetics in medicine open·2025
Same author

<i>BRAF</i> V600E Mutation Has Variable Tumor-Specific Effects on Expression of MAPK Pathway Genes That Could Affect Patient Outcome.

International journal of molecular sciences·2025
Same author

Alarming implications: severe fever with thrombocytopenia syndrome and its biological vectors in the context of climate change.

Frontiers in microbiology·2025

Related Experiment Video

Updated: Mar 10, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.5K

Humoral Immunity Profiling of Subjects with Myalgic Encephalomyelitis Using a Random Peptide Microarray

Sahajpreet Singh1, Phillip Stafford2, Karen A Schlauch3,4

  • 1Nevada Center for Biomedical Research, 1664 N Virginia St. MS 0552, Reno, NV, 89557-0552, USA.

Molecular Neurobiology
|December 17, 2016
PubMed
Summary
This summary is machine-generated.

Researchers identified a unique immunosignature, a pattern of antibodies, to diagnose Myalgic Encephalomyelitis (ME). This diagnostic signature uses a peptide microarray to detect antibodies, potentially revealing the disease

Keywords:
AntibodyChronic fatigue syndromeImmunosignatureMyalgic encephalomyelitisPeptide array

More Related Videos

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.7K
Analysis of Histone Antibody Specificity with Peptide Microarrays
09:47

Analysis of Histone Antibody Specificity with Peptide Microarrays

Published on: August 1, 2017

42.1K

Related Experiment Videos

Last Updated: Mar 10, 2026

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
09:12

A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection

Published on: June 15, 2018

10.5K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.7K
Analysis of Histone Antibody Specificity with Peptide Microarrays
09:47

Analysis of Histone Antibody Specificity with Peptide Microarrays

Published on: August 1, 2017

42.1K

Area of Science:

  • Immunology
  • Biomarker Discovery
  • Neuroscience

Background:

  • Myalgic encephalomyelitis (ME) is a complex, heterogeneous illness with unknown causes.
  • Identifying reliable biomarkers for ME diagnosis remains a significant challenge in current research.
  • Current research focuses on finding biomarkers, but an immunosignature approach offers a novel diagnostic strategy.

Purpose of the Study:

  • To develop a diagnostic signature for Myalgic Encephalomyelitis (ME) using an immunosignature approach.
  • To identify specific antibodies in ME patients' sera that can differentiate them from healthy controls.
  • To explore potential candidate antigens associated with ME pathogenesis through antibody-antigen interactions.

Main Methods:

  • Utilized a custom 125,000 random 12-mer peptide microarray.
  • Probed the microarray with sera from 21 ME cases and 21 controls from the USA and Europe.
  • Employed Basic Local Alignment Search Tool (BLAST) to analyze peptide sequences and identify potential antigens.

Main Results:

  • A distinct subset of 25 peptides was identified that effectively distinguished ME cases from controls with high specificity and sensitivity.
  • BLAST analysis indicated that these distinguishing peptides predominantly represent human self-antigens and endogenous retroviral sequences.
  • A minor proportion of the identified peptides showed homology to viral and bacterial pathogens.

Conclusions:

  • The study successfully developed a novel immunosignature-based diagnostic signature for Myalgic Encephalomyelitis (ME).
  • The findings suggest that autoimmune responses against self-antigens and endogenous retroviruses may play a role in ME.
  • This approach provides a promising avenue for ME biomarker discovery and understanding disease mechanisms.